ALICIA WHORTON: Open Payments
NPI 1508490806 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$232 in 13 payments from 7 companies in 2025. Trend: 2023 $23 · 2024 $351 · 2025 $232
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 4 | $59 |
| Organon LLC | 3 | $58 |
| Exeltis, USA Inc. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $19 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: NEXPLANON, SLYND, Veozah, MYFEMBREE, The Cologuard Plus Collection Kit, INGREZZA.
Industry payments across IL — which companies pay providers there.
